greeksoup/ stock research

Rapid Micro Biosystems, Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 13 May 2026: press release. Guidance figures: 2 new, 3 kept. The quarter’s numbers.

Key takeaways

  • Total revenue rose 11%: Total revenue was $8.0 million, up 11.1% from $7.2 million in the first quarter of 2025. Source
  • Net loss and per-share loss rose: Net loss was $14.3 million, or $0.31 per share, against $11.3 million, or $0.26 per share, a year earlier. Source
  • Recurring revenue rose 28%: Recurring revenue was $5.1 million, up 27.7% from $4.0 million in the first quarter of 2025. Source
  • Six Growth Direct systems placed: The company placed six Growth Direct systems and completed validation of five customer systems in the quarter. Source
  • Gross margin was 4.6%: Gross margin was 4.6%, or $0.4 million, against 5.6%, or $0.4 million, in the first quarter of 2025. Source
  • Operating expenses rose 18%: Total operating expenses were $14.2 million, up 17.9% from $12.1 million a year earlier. Source
  • Cash and investments near $23 million: Cash, cash equivalents, investments and restricted cash totaled $23.2 million, compared with $38.6 million at December 31, 2025. Source

“Our first quarter results reflect strong and consistent execution across the business,”

Robert Spignesi, President and CEO

Guidance

AreaPeriodFigureAgainst last quarter
Total revenue Sourcefull year 2026$37.0 million to $41.0 millionKept
Growth Direct system placements Sourcefull year 202630 to 38Kept
System validations Sourcefull year 2026at least 25New
Gross margin percentage Sourcefull year 2026approximately 20%Kept
Gross margin percentage exit rate Sourcefourth quarter 2026mid-20% rangeNew

What changed from last quarter

  • Guidance kept: Full-year 2026 revenue range and placement range were reaffirmed without change from the prior release. Source
  • New guidance: Full-year 2026 guidance for at least 25 customer system validations appears in this release. Source
  • New guidance: A fourth-quarter 2026 gross margin exit rate in the mid-20% range was added to guidance. Source
  • New: The company reported advancing its MilliporeSigma collaboration through execution of a Services Agreement. Source

Results and growth drivers

  • Total revenue rose 11%: Total revenue was $8.0 million, up 11.1% from $7.2 million in the first quarter of 2025. Source
  • Product revenue rose 36%: Product revenue was $5.6 million, up 36.0% from $4.1 million a year earlier. Source
  • Net loss and per-share loss rose: Net loss was $14.3 million, or $0.31 per share, against $11.3 million, or $0.26 per share, a year earlier. Source

Recurring and service revenue

  • Recurring revenue rose 28%: Recurring revenue was $5.1 million, up 27.7% from $4.0 million in the first quarter of 2025. Source
  • Recurring share reached 63%: Management said recurring revenue comprised 63% of total revenue in the quarter. Source
  • Consumable revenue grew over 30%: Consumable revenue increased by more than 30% year over year, within product revenue. Source
  • Service revenue fell 22%: Service revenue was $2.4 million, down 21.9% from $3.1 million, which management linked to lower validation activity. Source

“Strong consumable revenue drove nearly 30% growth in recurring revenue, underscoring the strength of our installed base and utilization trends.”

Robert Spignesi, President and CEO

Placements, validations and collaboration

  • Six Growth Direct systems placed: The company placed six Growth Direct systems and completed validation of five customer systems in the quarter. Source
  • Placements and validations versus prior year: Placements were three and validations were nine in the first quarter of 2025. Source
  • MilliporeSigma services agreement executed: The company said it advanced its strategic collaboration with MilliporeSigma and executed a Services Agreement. Source

Costs, margins and operating expenses

  • Gross margin was 4.6%: Gross margin was 4.6%, or $0.4 million, against 5.6%, or $0.4 million, in the first quarter of 2025. Source
  • Product and consumable margins improved: Product gross margin percentage rose 15 percentage points and consumable gross margin rose 33 percentage points. Source
  • Cost of revenue rose 12%: Total cost of revenue was $7.6 million, up 12.2% from $6.8 million a year earlier. Source
  • Operating expenses rose 18%: Total operating expenses were $14.2 million, up 17.9% from $12.1 million a year earlier. Source
  • Expense lines moved in different directions: G&A rose 30.8%, sales and marketing rose 24.4%, and R&D fell 7.3%, each compared with the first quarter of 2025. Source

“We continue to see robust customer interest in QC automation and are increasingly engaged in strategic discussions with customers on enterprise-level deployments of the Growth Direct platform”

Robert Spignesi, President and CEO

Cash, balance sheet and capital

  • Cash and investments near $23 million: Cash, cash equivalents, investments and restricted cash totaled $23.2 million, compared with $38.6 million at December 31, 2025. Source
  • Cash and short-term investments split: Cash and cash equivalents were $13.8 million and short-term investments were $9.1 million at March 31, 2026. Source
  • Receivables rose, inventory flat: Accounts receivable were $6.4 million, up from $3.1 million, and inventory, net was $17.4 million, from $17.6 million. Source
  • Deferred revenue increased: Deferred revenue was $6.6 million at March 31, 2026, up from $4.7 million at December 31, 2025. Source
  • Interest expense increased: Interest expense was $639 thousand, compared with $12 thousand in the first quarter of 2025. Source

Demand and customer engagement

  • Customer interest in QC automation: Management described customer interest in QC automation as robust. Source
  • Enterprise-level deployment discussions: Management said it is increasingly in strategic discussions with customers on enterprise-level deployments. Source
  • Company-wide automation integration: Management described discussions on broader integration of the Growth Direct platform into company-wide automation strategies. Source

Figures management reported

FigureReported
Growth Direct systems placed Source6 in first quarter 2026 (3 in first quarter 2025)
Customer systems validated Source5 in first quarter 2026 (9 in first quarter 2025)
Consumable revenue growth Sourceover 30% year over year
Recurring revenue share of total revenue Source63%

Risks management discussed

  • Demand: Service revenue declined because validation activity was lower than in the prior-year quarter. Source

Earlier plans management reported on

  • Not stated: Management reaffirmed the full-year 2026 revenue and placement guidance given earlier; the release does not describe progress against it. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.